Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay.

Cao W, Cho CD, Geng ZZ, Shaabani N, Ma XR, Vatansever EC, Alugubelli YR, Ma Y, Chaki SP, Ellenburg WH, Yang KS, Qiao Y, Allen R, Neuman BW, Ji H, Xu S, Liu WR

Open source

DOI: 10.1021/acscentsci.1c00910
Published: 2022 Feb 23
Container: ACS central science
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acscentsci.1c00910,
  title = {Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay.},
  author = {Cao W and Cho CD and Geng ZZ and Shaabani N and Ma XR and Vatansever EC and Alugubelli YR and Ma Y and Chaki SP and Ellenburg WH and Yang KS and Qiao Y and Allen R and Neuman BW and Ji H and Xu S and Liu WR},
  year = {2022},
  journal = {ACS central science},
  doi = {10.1021/acscentsci.1c00910},
  url = {https://doi.org/10.1021/acscentsci.1c00910}
}

RIS

TY  - JOUR
TI  - Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay.
AU  - Cao W
AU  - Cho CD
AU  - Geng ZZ
AU  - Shaabani N
AU  - Ma XR
AU  - Vatansever EC
AU  - Alugubelli YR
AU  - Ma Y
AU  - Chaki SP
AU  - Ellenburg WH
AU  - Yang KS
AU  - Qiao Y
AU  - Allen R
AU  - Neuman BW
AU  - Ji H
AU  - Xu S
AU  - Liu WR
PY  - 2022
JO  - ACS central science
DO  - 10.1021/acscentsci.1c00910
UR  - https://doi.org/10.1021/acscentsci.1c00910
ER  -

APA

W, C., CD, C., ZZ, G., N, S., XR, M., EC, V., YR, A., Y, M., SP, C., WH, E., KS, Y., Y, Q., R, A., BW, N., H, J., S, X., & WR, L. (2022). Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay.. ACS central science. https://doi.org/10.1021/acscentsci.1c00910

Source records

pubmed · retrieved 2026-09-26T21:27:20.101Z